El diagnóstico de obesidad sarcopénica podría añadir un plus de repercusiones clínicas a la obesidad grave

INTRODUCTION: Sarcopenic obesity (SO) is characterized by the coexistence of excess body fat and reduced muscle mass and strength. It is associated with increased cardiovascular and metabolic risk and entails greater disability, limiting patients' quality of life and increasing the risk of mortality. OBJECTIVE: To assess whether the diagnosis of SO adds an extra clinical impact in patients with severe obesity who are candidates for bariatric surgery. MATERIAL AND METHODS: with comorbidities) aged 18 to 60years. Collection of sociodemographic, clinical, anthropometric, quality of life (EuroQol-5D), analytical variables and use of health resources. Evaluation of body composition by DXA (fat mass and appendicular lean mass [MMA]), muscle strength (hand grip dynamometry) and physical performance (Timed-up-and-Go). Diagnosis of SO according to ESPEN/EASO criteria. RESULTS: 28 patients (22.6%) had SO. Patients with SO had higher weight, BMI, waist circumference and calf (P